Medical research

New target for COVID-19 vaccines identified

Next generation vaccines for COVID-19 should aim to induce an immune response against 'replication proteins', essential for the very earliest stages of the viral cycle, concludes new research carried out by UCL scientists.

Diseases, Conditions, Syndromes

How many people get 'long COVID?' More than half, researchers find

More than half of the 236 million people who have been diagnosed with COVID-19 worldwide since December 2019 will experience post-COVID symptoms—more commonly known as "long COVID"—up to six months after recovering, according ...

Diseases, Conditions, Syndromes

Nigeria first to use 'revolutionary' meningitis jab: WHO

Africa's most populous nation Nigeria has launched a "revolutionary" vaccine against meningitis, in what the World Health Organization (WHO) on Friday said was a world first.

page 7 from 40